Breakthrough Genetic Sensor Enables MRIs to Detect Molecular-Level Changes in Real Time

Since the 1970s, magnetic resonance imaging (MRI) has been a cornerstone of medical diagnostics, providing detailed images of the body’s internal structures—such as the brain, heart, bones, and organs—without exposing patients to ionizing radiation. While MRIs excel at capturing anatomical changes, they have long been limited in their ability to detect molecular-level activity, which could offer critical insights into disease progression.

Now, a team of researchers from the University of California, Santa Barbara (UCSB) has developed a genetically encoded, protein-based sensor that could bridge this gap. In a new study published in Science Advances, the team reports that this modular sensor enables MRI machines to visualize molecular activity inside cells in real time—a breakthrough that could transform research in cancer, neurodegeneration, and inflammation.

How the Sensor Works

Traditional MRI scans provide structural snapshots, but they lack the ability to detect early molecular changes that precede visible anatomical alterations. Arnab Mukherjee, an associate professor of chemical engineering at UCSB’s Robert Mehrabian College of Engineering and lead researcher on the project, explains the limitation:

“You can see the structures of your tissues—whether it’s the brain, the heart, the kidneys, or the stomach—but you don’t get molecular information. So, the only time you can know that something is going wrong or something has changed is if you take another MRI, and the structure and morphology of the tissue changes.”

For many diseases, by the time structural changes are detectable via MRI, the condition has already progressed significantly. Mukherjee, who has been refining MRI technology since his postdoctoral research at the California Institute of Technology (Caltech), sought to address this gap by developing a sensor capable of capturing real-time molecular changes.

Key Innovations and Applications

The newly developed sensor is modular and genetically encodable, meaning it can be engineered into cells to target specific molecular processes. Its design is likened to a LEGO-like architecture, allowing researchers to attach or substitute proteins to monitor different cellular activities. This flexibility could unlock new avenues of research, including:

• Understanding how tumor cells metastasize at the molecular level.
• Investigating the progression of neurodegenerative diseases as an organism ages.
• Studying inflammation and other irregularities that drive health changes.

“If we can see these molecular-level changes happening in real time,” Mukherjee says, “then we can ask questions like, ‘How do tumor cells metastasize?’ or ‘How does neurodegeneration progress at the molecular level as an animal ages?’ There’s currently no way to do that.”

Overcoming MRI Limitations

MRI technology relies on a strong magnetic field to align hydrogen atoms within the body, followed by radio waves to generate images. However, detecting molecular activity requires a sensor that the MRI can “see” within cells and tissues. Mukherjee and his team achieved this by designing a protein-based sensor that interacts with the MRI’s magnetic field, enabling it to visualize fine-grained molecular changes.

The sensor’s modular design allows researchers to customize it for specific applications, making it a versatile tool for both basic science and preclinical studies. While the technology is still in its early stages, it holds immense potential for future human health applications, including earlier disease detection and more targeted treatments.